The study, assessing the effectiveness of the Spanish DCT app, Radar COVID, used a simulated series of COVID-19 infections in the Canary Islands to understand whether DCT apps work effectively in the real world. The researchers found that over 30% of the population downloaded and utilised the DCT app and that it was able to detect over twice the national average close-contacts per individual (6.3 per individual), than manual contract tracing alone. However, the researcher’s suggested that the app’s effectiveness is dependent on the national and local campaign to encourage people to download the DCT app.
“Overall our results were positive and show that the technology works and if accompanied by appropriate communications campaigns, it should reach the levels of adoption and compliance needed to support other non-pharmaceutical interventions to contain outbreaks.”
Dr Lucas Lacasa, Reader in Applied Mathematics at Queen Mary University of London and author of the study
Click here to learn more.
SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.